Guilbaud, Emma
Sarosiek, Kristopher A. http://orcid.org/0000-0002-4618-5085
Galluzzi, Lorenzo http://orcid.org/0000-0003-2257-8500
Article History
Received: 1 March 2024
Accepted: 12 April 2024
First Online: 20 April 2024
Competing interests
: L.G. is/has been holding research contracts with Lytix Biopharma, Promontory, and Onxeo, has received consulting/advisory honoraria from Boehringer Ingelheim, AstraZeneca, OmniSEQ, Onxeo, The Longevity Labs, Inzen, Imvax, Sotio, Promontory, Noxopharm, EduCom, and the Luke Heller TECPR2 Foundation, and holds Promontory stock options. E.G. and K.A.S. have no conflicts of interest to declare.